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Background
The BRAF p.V600E somatic mutation is present in
approximately 10-20% of unselected colorectal cancer
(CRC) and 30% -75% of CRCs demonstrating high levels
of microsatellite instability (MSI-H). Currently, testing
for the BRAF p.V600E mutation is undertaken to
exclude Lynch syndrome in MSI-H CRCs that demon-
strate loss of the MLH1 and PMS2 proteins by IHC.
However, recent evidence suggests that the BRAF p.
V600E mutation is associated with a familial predisposi-
tion to serrated neoplasia, an increased risk of CRC and
possibly extra-colonic cancers in relatives. The aim of
this study was to determine 1) if early-onset CRC with
the BRAF p.V600E mutation is associated with a family
history of CRC, and 2) if pathological features of BRAF
positive CRCs associate with CRC development in
relatives.
Methods
Population-based recruitment of probands into the Aus-
tralasian Colon Cancer Family Study between 1997 and
2006 was undertaken for newly diagnosed CRC irrespec-
tive of any family history of cancer but limited to a first
primary adenocarcinoma of the colon or rectum
between the ages of 18-60yrs. Patients with Lynch syn-
drome and MutYH associated polyposis were excluded
from the analysis. The BRAF p.V600E mutation was
determined using a previously described allele-specific
PCR assay on DNA from formalin-fixed paraffin
embedded colorectal cancer tissue.
Results
The average age of onset for the 709 probands (49.5%
female) was 46.3yrs ± 7.9yrs (SD) with a range of 18yrs
to 60yrs. A history of CRC in at least one first degree
relative (FDR) or second degree relative (SDR) was
reported in 39.5% (280/709) of the probands. The BRAF
p.V600E mutation was present in 54/709 (7.6%) CRCs.
Overall, probands with a BRAF p.V600E positive CRC
were less likely to have a FDR with CRC than probands
with a BRAF wildtype CRC (OR=0.42, 95%CI=0.16-1.09;
P=0.07) regardless of MSI status. Among the probands
with a BRAF p.V600E mutated CRC, the mean age at
diagnosis was significantly older for probands with a
CRC-affected FDR or SDR (50.4 years, 95%CI=47.1–
53.7) when compared to probands without a family his-
tory (44.0 years, 95%CI=40.7–42.3; P = 0.02). The odds
(risk) of having a family history of CRC significantly
increased 11% per year of age (OR 1.11; 95% CI 1.01 –
1.21; P = 0.02) in probands with a BRAF p.V600E muta-
tion positive CRC. When considering only BRAF p.
V600E positive CRC, a mucinous histology was
increased 4.4 fold in probands with a FDR or SDR with
CRC (n=17) when compared to probands without a
family history of CRC (n=37), although this was not
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P=0.15).
Conclusions
In this study of early-onset CRC, we describe evidence
for a relationship between the BRAF p.V600E mutation
and a family history of CRC that is related to an increas-
ing age of CRC onset. These findings, in conjunction
with observations suggesting certain pathological fea-
tures are associated with a family history of CRC in
BRAF p.V600E mutated CRC warrant further
investigation.
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